The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog is intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at www.Vicus.com, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Support this site

    If you found the information here helpful, please consider supporting this site.If you found the information here helpful, please consider supporting this site.

  • Recent Posts

  • Recent Comments

    The benefits of omega-3 fatty acids in people with type 2 diabetes

    A moderate dose of omega-3 polyunsaturated fatty acids (PUFAs) for 2 months reduced adiposity and atherogenic markers, and had no negative effect on insulin sensitivity.

    First, the details.

    • 27 women with type 2 diabetes and normal blood triglyceride levels were randomly allocated to 2 months of 3 grams/day of either fish oil (1.8 grams omega-3 PUFAs) or placebo (paraffin oil).
    • The women and researchers were not aware of the treatment given.

    And, the results.

    • Body weight and energy intake measured using a food diary were unchanged.
    • But total fat and subcutaneous fat cell diameter were significantly lower in the fish oil group.
    • Insulin sensitivity was not different between the groups.
    • By contrast, atherogenic risk factors (ie, triglyceride blood levels, the ratio of triglyceride to HDL good cholesterol, and plasma plasminogen activator inhibitor were lower (better) in the fish oil group than in the placebo group.
    • Some inflammation-related genes were also reduced in subcutaneous fat tissue after the fish oil, but not the placebo.

    The bottom line?
    The reduced fat tissue combined with the positive effects on lipids in the absence of deteriorating insulin sensitivity are positive findings for omega-3 in people with type 2 diabetes.

    12/22/07 1:08 JR

    Leave a Comment

    You must be logged in to post a comment.